Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes.
Maurer, Carlo; Holmstrom, Sam R; He, Jing; Laise, Pasquale; Su, Tao; Ahmed, Aqeel; Hibshoosh, Hanina; Chabot, John A; Oberstein, Paul E; Sepulveda, Antonia R; Genkinger, Jeanine M; Zhang, Jiapeng; Iuga, Alina C; Bansal, Mukesh; Califano, Andrea; Olive, Kenneth P.
; 68(6): 1034-1043, 2019 06.
Artigo em Inglês | MEDLINE | ID: mdl-30658994
Pancreatic Cancer: "A Riddle Wrapped in a Mystery inside an Enigma".
International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.
[Progress in clinical research of pancreatic cancer: from "resection" to "cure"].
Redefining the Positive Margin in Pancreatic Cancer: Impact on Patterns of Failure, Long-Term Survival and Adjuvant Therapy.
Impact of neoadjuvant therapy on postoperative outcomes after pancreaticoduodenectomy.
Nuclear ubiquitin C-terminal hydrolase L5 expression associates with increased patient survival in pancreatic ductal adenocarcinoma.
Adjuvant treatment of surgically resectable pancreatic ductal adenocarcinoma.
Preoperative maximum standardized uptake value and carbohydrate antigen 19-9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinoma.
Proteomic identification of potential prognostic biomarkers in resectable pancreatic ductal adenocarcinoma.
[A Case Report of Conversion Surgery for Pancreatic Ductal Adenocarcinoma with Liver Metastasis after Chemotherapy].